<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2087">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04292964</url>
  </required_header>
  <id_info>
    <org_study_id>2020-02-2</org_study_id>
    <nct_id>NCT04292964</nct_id>
  </id_info>
  <brief_title>Prognostic Factors of Patients With COVID-19</brief_title>
  <official_title>Prognostic Factors of Patients With COVID-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chongqing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chongqing Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
      syndrome coronavirus 2 (SARS-CoV-2) in China has been declared a public health emergency of
      international concern. Despite lower mortality rate, SARS-CoV-2 has killed more people than
      SARS and MERS and the number keeps growing. Epidemic studies have been well described
      clinical features of patients with COVID-19, with the disease severity being an independent
      predictor of poor outcome. However, there is still no research investigating the prognostic
      factors of patients with COVID-19.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2020</start_date>
  <completion_date type="Actual">March 13, 2020</completion_date>
  <primary_completion_date type="Actual">March 13, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>all-cause mortality</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>all-cause mortality</measure>
    <time_frame>15 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe state</measure>
    <time_frame>15 days</time_frame>
    <description>Criteria for severe or critical ill conditions: Respiratory rate &gt;=30/min; or Rest SPO2&lt;=93%; or PaO2/FiO2&lt;=300mmHg.</description>
  </secondary_outcome>
  <enrollment type="Actual">201</enrollment>
  <condition>SARS-CoV-2</condition>
  <condition>Outcome, Fatal</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with COVID-19
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult aged &gt;=18years old;

          -  Diagnosed with CONVID19. Diagnostic criteria including: Laboratory (RT-PCR) confirmed
             SARS-Cov-2 infection; CT of the lung conformed to the manifestation of viral
             pneumonia.

          -  Criteria for severe or critical ill conditions: Respiratory rate &gt;=30/min; or Rest
             SPO2&lt;=93%; or PaO2/FiO2&lt;=300mmHg.

        Exclusion Criteria:

          -  Near-death state (expected survival time less than 24 hours);

          -  Malignant tumor;

          -  Pregnancy or puerperium women;

          -  Patients who refused to participant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Chongqing Medical University</name>
      <address>
        <city>Chongqing</city>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 1, 2020</study_first_submitted>
  <study_first_submitted_qc>March 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2020</study_first_posted>
  <last_update_submitted>March 13, 2020</last_update_submitted>
  <last_update_submitted_qc>March 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chongqing Medical University</investigator_affiliation>
    <investigator_full_name>Dongying Zhang</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

